Referred to the House Committee on Energy and Commerce.
The bill reauthorizes and amends a CDC-administered WISEWOMAN supplemental grants program to provide additional preventive services for women. It authorizes grants for blood pressure and cholesterol screening, health education, referrals, follow-up, and program evaluation.
Appropriate federal funding level and scope of program expansion
Relative to its intended legislative type, this bill is a straightforward statutory reauthorization and expansion of an existing federal grant program.
The bill reauthorizes and amends a CDC-administered WISEWOMAN supplemental grants program to provide additional preventive services for women.
It authorizes grants for blood pressure and cholesterol screening, health education, referrals, follow-up, and program evaluation.
Eligible recipients include women served under section 1501 and other low-income women; providers may be existing breast and cervical cancer screening entities or designated partners.
Modest-cost, administratively straightforward reauthorization with cross-aisle appeal; success mainly depends on appropriations and legislative scheduling.
Relative to its intended legislative type, this bill is a straightforward statutory reauthorization and expansion of an existing federal grant program. It clearly amends the Public Health Service Act, identifies implementing authority, enumerates permitted services and eligible populations in broad terms, and provides an explicit authorization of appropriations.
Appropriate federal funding level and scope of program expansion
These are examples from the analysis, not a ranked list of the most-affected groups.
Appropriate federal funding level and scope of program expansion
This persona would likely view the bill positively as an expansion of preventive care for women, especially low-income and underserved populations.
They would emphasize the equity gains from targeted screenings, referrals, and follow-up funded through the CDC.
They may press for stronger provisions on coverage, data disaggregation, and higher funding to meet unmet needs.
This persona would generally support the bill as pragmatic preventive health policy that builds on existing programs.
They would appreciate using CDC grants and leveraging breast/cervical screening infrastructure, while seeking accountability, measurable outcomes, and cost-effectiveness.
They would want clear performance metrics and oversight to justify the appropriations.
This persona would be cautious or skeptical, accepting preventive care goals but concerned about new federal spending and program expansion.
They would view the $250 million authorization as federal overreach and worry about duplication with state efforts or private-sector services.
They would press for tighter eligibility, state flexibility, and fiscal restraint.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest-cost, administratively straightforward reauthorization with cross-aisle appeal; success mainly depends on appropriations and legislative scheduling.
The bill has not accumulated any surfaced votes yet.
Appropriate federal funding level and scope of program expansion
Modest-cost, administratively straightforward reauthorization with cross-aisle appeal; success mainly depends on appropriations and legisla…
Relative to its intended legislative type, this bill is a straightforward statutory reauthorization and expansion of an existing federal grant program. It clearly amends the Public Health Service Act, identifies impleme…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.